NCT00398372已完成不适用
Le20: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 500
- 试验地点
- 2
- 主要终点
- To characterize the molecular and cell biology of the tumor cells in lymphoma.
研究概览
简要总结
To characterize the molecular and cell biology of the tumor cells in lymphoma. The mechanism of monoclonal antibody treatment by rituximab or epratuzumab will also be examined.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
排除标准
- 未提供
结局指标
主要结局
To characterize the molecular and cell biology of the tumor cells in lymphoma.
时间窗: 6 months
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's DiseaseLymphoma, Non-HodgkinHodgkin's DiseaseNCT00398177Stanford University9,999
进行中（未招募）
不适用
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.Non Hodgkin LymphomaMarginal Zone LymphomaDiffuse Large B Cell LymphomaFollicular LymphomaNCT06424379Hospices Civils de Lyon135
招募中
不适用
Tissue Collection for Studies of Lymph CancerHodgkin DiseaseLymphoma, Non-HodgkinLymphomatoid GranulomatosisLeukemia-Lymphoma, Adult T-CellMultiple MyelomaNCT01676805National Cancer Institute (NCI)1,295
已完成
不适用
Tumor immune infiltrates as prognostic biomarkers in oral cancerCTRI/2020/07/026335Kinjal Shankar Majumdar111
Unknown
不适用
A Single-cell Transcriptome Study in Patients With Non-Hodgkin's LymphomaNon Hodgkin LymphomaNCT04434833Ruijin Hospital150